Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Field Medical Appoints Mark A. Turco, MD, as New CEO to Lead Growth Initiatives Field Medical, Inc. has announced the appointment of Mark A. Turco, MD, as their new CEO. He brings over 30 years of relevant experience in medical technology and clinical trials.

Field Medical Appoints Mark A. Turco, MD, as New CEO to Lead Growth Initiatives #USA #Cardiff-by-the-Sea #Field_Medical #PFA_Solutions #Mark_Turco

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Field Medical Appoints Experienced Doctor Mark A. Turco as New CEO for Growth Strategy Field Medical, Inc. has appointed Dr. Mark A. Turco as CEO, bringing over 30 years of medical technology leadership to the company focused on PFA solutions for arrhythmias.

Field Medical Appoints Experienced Doctor Mark A. Turco as New CEO for Growth Strategy #USA #Field_Medical #Cardiff-by-the-Sea,_California #PFA_Technology #Mark_Turco

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Field Medical Appoints Dr. Mark A. Turco as New CEO to Drive Growth Initiatives Field Medical has officially appointed Dr. Mark A. Turco as CEO. With over 30 years of experience, he is set to lead the company's growth and innovation.

Field Medical Appoints Dr. Mark A. Turco as New CEO to Drive Growth Initiatives #USA #medical_technology #Cardiff-by-the-Sea #Field_Medical #Mark_A._Turco

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Mark A. Turco, MD, Appointed CEO of Field Medical to Drive Growth Field Medical, Inc. announces Mark A. Turco, MD, as its new CEO, aiming to spearhead the development of innovative cardiovascular technologies.

Mark A. Turco, MD, Appointed CEO of Field Medical to Drive Growth #USA #medical_technology #Cardiff-by-the-Sea #Field_Medical #Mark_Turco

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Field Medical Appoints Dr. Mark A. Turco as New CEO to Drive Growth and Innovation Field Medical has announced the appointment of Dr. Mark A. Turco as its new CEO, aiming to enhance its medical technology solutions and accelerate growth.

Field Medical Appoints Dr. Mark A. Turco as New CEO to Drive Growth and Innovation #United_States #Field_Medical #Cardiff-by-the-Sea,_California #Mark_A._Turco #PFA_Solutions

Thiard News@F4F

@newsen.bsky.social

1 month ago

Field Medical Unveils Groundbreaking Clinical Trial Results at AF Symposium 2026 Field Medical, Inc. presents significant clinical trial findings regarding their Pulse Ablation technology for complex cardiac arrhythmias during the AF Symposium 2026, showcasing remarkable advancements.

Field Medical Unveils Groundbreaking Clinical Trial Results at AF Symposium 2026 #USA #Boston #Field_Medical #AF_Symposium #PFA_Technology

Thiard News@F4F

@newsen.bsky.social

1 month ago

Field Medical Unveils Pioneering Field PULSE Trial Results at 2026 AF Symposium Field Medical presents groundbreaking results from the Field PULSE trial at the 2026 AF Symposium, showcasing innovative ablation techniques.

Field Medical Unveils Pioneering Field PULSE Trial Results at 2026 AF Symposium #USA #Boston #Field_Medical #PFA_Technology #FieldForce_System

Thiard News@F4F

@newsen.bsky.social

1 month ago

Field Medical Unveils Groundbreaking PULSE Study Insights at AF Symposium 2026 Field Medical, Inc. showcases innovative findings from the PULSE study on pulsed field ablation techniques at the AF Symposium 2026 in Boston.

Field Medical Unveils Groundbreaking PULSE Study Insights at AF Symposium 2026 #USA #Boston #Field_Medical #AF_Symposium #PULSE_Study

Thiard News@F4F

@newsen.bsky.social

1 month ago

Field Medical Unveils Groundbreaking Trial Results for Cardiac Ablation Technology at AF Symposium 2026 Field Medical, Inc. showcases late-breaking trial data for their pulsed field ablation technology, revolutionizing cardiac arrhythmia treatment at AF Symposium 2026.

Field Medical Unveils Groundbreaking Trial Results for Cardiac Ablation Technology at AF Symposium 2026 #USA #Boston #Field_Medical #FieldForce #AF_Symposium

Thiard News@F4F

@newsen.bsky.social

1 month ago

Field Medical Unveils Latest Trial Results for PFA Technology at AF Symposium 2026 Field Medical, Inc. presented groundbreaking results from the Field PULSE study, showcasing innovations in pulsed field ablation technology during AF Symposium 2026.

Field Medical Unveils Latest Trial Results for PFA Technology at AF Symposium 2026 #USA #Boston #Field_Medical #AF_Symposium #PFA_Technology

Thiard News@F4F

@newsen.bsky.social

2 months ago

Field Medical to Showcase Innovative Technology at J.P. Morgan Healthcare Conference Field Medical Inc., a clinical-stage firm, will present its cutting-edge pulsed field ablation technology at the upcoming J.P. Morgan Healthcare Conference in San Francisco.

Field Medical to Showcase Innovative Technology at J.P. Morgan Healthcare Conference #USA #San_Francisco #J.P._Morgan #Field_Medical #PFA_Technology

Thiard News@F4F

@newsen.bsky.social

2 months ago

Field Medical to Present Its Innovative Cardiac Ablation Technology at J.P. Morgan's Annual Healthcare Conference Field Medical Inc. is set to unveil its groundbreaking cardiac ablation platform at the 44th J.P. Morgan Annual Healthcare Conference.

Field Medical to Present Its Innovative Cardiac Ablation Technology at J.P. Morgan's Annual Healthcare Conference #USA #San_Francisco #Field_Medical #FieldForce #cardiac_ablation

Thiard News@F4F

@newsen.bsky.social

2 months ago

Field Medical Inc. Showcases Innovative Technology at J.P. Morgan Healthcare Conference Field Medical Inc. is set to present its groundbreaking pulsed field ablation platform at the upcoming J.P. Morgan Healthcare Conference, highlighting advancements in cardiac treatments.

Field Medical Inc. Showcases Innovative Technology at J.P. Morgan Healthcare Conference #Healthcare_Conference #Field_Medical #PFA_Platform

Thiard News@F4F

@newsen.bsky.social

2 months ago

Field Medical Set to Showcase Groundbreaking Technology at J.P. Morgan Healthcare Conference Field Medical Inc. announces participation in the J.P. Morgan Healthcare Conference, introducing their innovative pulsed field ablation platform.

Field Medical Set to Showcase Groundbreaking Technology at J.P. Morgan Healthcare Conference #USA #San_Francisco #Field_Medical #FieldForce #Ablation_System

Thiard News@F4F

@newsen.bsky.social

5 months ago

Field Medical Unveils Promising Results of First VCAS Human Trial for Ventricular Ablation Field Medical's FieldForce™ Ablation System shows significant promise in treating ventricular tachycardia, presenting 82% reduction in recurrences and 98% decrease in episodes.

Field Medical Unveils Promising Results of First VCAS Human Trial for Ventricular Ablation #United_States #New_York #Field_Medical #FieldForce #VCAS_trial

Thiard News@F4F

@newsen.bsky.social

5 months ago

Field Medical's Groundbreaking Study Shows Promising Results for VT Treatment Using FieldForce™ System Recent findings from a trial using Field Medical's FieldForce™ Pulsed Field Ablation System reveal significant success in treating ventricular tachycardia, showcasing an 82% success rate.

Field Medical's Groundbreaking Study Shows Promising Results for VT Treatment Using FieldForce™ System #USA #FieldForce™ #Ventricular_Tachycardia #Cardiff-by-the-Sea #Field_Medical

Thiard News@F4F

@newsen.bsky.social

5 months ago

Promising Outcomes Revealed for FieldForce™ In-Vivo Trial in Vascular Ablation New insights from the six-month outcomes of the VCAS trial highlight Field Medical, Inc.'s innovative FieldForce™ Ablation System's potential impact on ventricular tachycardia treatment.

Promising Outcomes Revealed for FieldForce™ In-Vivo Trial in Vascular Ablation #USA #FieldForce™ #Cardiff-by-the-Sea #Field_Medical #VCAS

Thiard News@F4F

@newsen.bsky.social

5 months ago

Groundbreaking Results from Field Medical's FieldForce™ System for Ventricular Tachycardia Ablation Field Medical, Inc. has made significant strides in cardiac care with the VCAS study, revealing 82% absence of VT/VF recurrence using their FieldForce™ system.

Groundbreaking Results from Field Medical's FieldForce™ System for Ventricular Tachycardia Ablation #USA #Philadelphia #Field_Medical #FieldForce #VT

Thiard News@F4F

@newsen.bsky.social

5 months ago

Field Medical Presents Breakthrough Clinical Trial Data at VT Symposium 2025 Field Medical Inc. shares groundbreaking results from its first six months of clinical trials at the VT Symposium 2025 in Philadelphia.

Field Medical Presents Breakthrough Clinical Trial Data at VT Symposium 2025 #United_States #Philadelphia #Field_Medical #FieldForce #VT_Symposium

Thiard News@F4F

@newsen.bsky.social

5 months ago

Field Medical Shares Groundbreaking Six-Month Data at VT Symposium 2025 on Innovative Therapy for Ventricular Tachycardia Field Medical, Inc. is set to present its first six-month data on ground-breaking ventricular tachycardia therapy at the VT Symposium 2025, showcasing innovations in cardiac care.

Field Medical Shares Groundbreaking Six-Month Data at VT Symposium 2025 on Innovative Therapy for Ventricular Tachycardia #USA #Philadelphia #Field_Medical #FieldForce #VT_Symposium

Thiard News@F4F

@newsen.bsky.social

5 months ago

Field Medical Unveils Revolutionary 6-Month Data for VT Treatment at Upcoming Symposium Field Medical, Inc. will present groundbreaking data on its FieldForce™ Ablation System at the VT Symposium 2025, highlighting its innovative approach to ventricular tachycardia treatment.

Field Medical Unveils Revolutionary 6-Month Data for VT Treatment at Upcoming Symposium #USA #Philadelphia #Field_Medical #FieldForce #VT_Symposium

Thiard News@F4F

@newsen.bsky.social

5 months ago

Field Medical Showcases Groundbreaking 6-Month Human Data at VT Symposium 2025 Field Medical, Inc. presents pioneering 6-month human data at the VT Symposium 2025, showcasing their innovative pulsed field ablation technology.

Field Medical Showcases Groundbreaking 6-Month Human Data at VT Symposium 2025 #USA #Philadelphia #Field_Medical #FieldForce #VT_Symposium

Thiard News@F4F

@newsen.bsky.social

5 months ago

Field Medical Showcases Pioneering VT Ablation Results at Upcoming Symposium Field Medical, Inc. reveals first-in-human data on its innovative VT treatment at the VT Symposium 2025, highlighting advancements in cardiac care.

Field Medical Showcases Pioneering VT Ablation Results at Upcoming Symposium #USA #Philadelphia #Health_Technology #Field_Medical #VT_Ablation

Thiard News@F4F

@newsen.bsky.social

8 months ago

Field Medical Secures $35 Million Series B Funding for Heart Ablation Technology Development Field Medical, Inc. has completed a $35 million Series B funding round aimed at advancing its cutting-edge heart ablation technology, FieldForce™.

Field Medical Secures $35 Million Series B Funding for Heart Ablation Technology Development #USA #Heart_Ablation #Cardiff-by-the-Sea #Field_Medical #FieldForce

Thiard News@F4F

@newsen.bsky.social

8 months ago

Field Medical Secures $35 Million to Accelerate Cardiac Ablation Innovations Field Medical announces a $35 million Series B funding to boost development of their next-generation FieldForce™ cardiac ablation system, enhancing ventricular tachycardia treatments.

Field Medical Secures $35 Million to Accelerate Cardiac Ablation Innovations #USA #Ventricular_Tachycardia #Cardiff-by-the-Sea #Field_Medical #FieldForce

Thiard News@F4F

@newsen.bsky.social

8 months ago

Field Medical Raises $35 Million to Develop Innovative Pulsed Field Ablation Platform Field Medical has secured $35 million in a Series B funding round, aimed at advancing its FieldForce™ pulsed field ablation technology and enhancing clinical capabilities.

Field Medical Raises $35 Million to Develop Innovative Pulsed Field Ablation Platform #USA #Cardiff-by-the-Sea #Field_Medical #FieldForce #Pulsed_Field_Ablation

Thiard News@F4F

@newsen.bsky.social

8 months ago

Field Medical Secures $35 Million Series B Funding to Revolutionize Cardiac Care with Advanced Ablation Technology Field Medical, a pioneering company in cardiac ablation technology, recently closed a $35 million Series B round to enhance its innovative FieldForce™ system aimed at treating ventricular tachycardia.

Field Medical Secures $35 Million Series B Funding to Revolutionize Cardiac Care with Advanced Ablation Technology #USA #Cardiff-by-the-Sea #Field_Medical #FieldForce #cardiac_ablation

Thiard News@F4F

@newsen.bsky.social

8 months ago

Field Medical Secures $35 Million to Propel Innovative Cardiac Ablation Technology Forward Field Medical has successfully closed a $35 million Series B financing round aimed at advancing the development of its FieldForce™ Pulsed Field Ablation platform to treat complex cardiac conditions.

Field Medical Secures $35 Million to Propel Innovative Cardiac Ablation Technology Forward #USA #Cardiff-by-the-Sea #Field_Medical #FieldForce #cardiac_ablation

Thiard News@F4F

@newsen.bsky.social

11 months ago

Field Medical Presents Revolutionary Data on Focal PFA for Scar-Related VT at Heart Rhythm 2025 Field Medical Inc. will reveal groundbreaking findings on focal pulsed field ablation for scar-related ventricular tachycardia at Heart Rhythm 2025, showcasing their cutting-edge technology.

Field Medical Presents Revolutionary Data on Focal PFA for Scar-Related VT at Heart Rhythm 2025 #USA #San_Diego #Field_Medical #Heart_Rhythm #PFA

Thiard News@F4F

@newsen.bsky.social

11 months ago

Field Medical Unveils First Human Data on Focal PFA for Scar VT at Heart Rhythm 2025 Field Medical Inc has announced significant advancements with its FieldForce Ablation System, showcasing key human data on focal PFA for scar-related ventricular tachycardia at Heart Rhythm 2025.

Field Medical Unveils First Human Data on Focal PFA for Scar VT at Heart Rhythm 2025 #USA #San_Diego #Field_Medical #FieldForce #scar_VT